MEGA |
MEGA LIFESCIENCES PUBLIC COMPANY LIMITED |
Services/Commerce |
SET100 / SETCLMV / SETWB |
CG Report:    |
|
|
|
|
Price (B.) |
52 Week High/Low |
P/E (X) |
P/BV (X) |
Paid-up (MB.) |
Market Cap (MB.) |
EV (MB.) |
EBITDA (MB.) |
EV/EBITDA |
48.00 |
56.50 / 40.25 |
18.26 |
4.87 |
435.93 |
41,849.74 |
44,649.25 | 789.34 |
15.45 |
|
News |
Date/Time |
Subject |
11 Aug 2022 17:19 | Interim dividend payment 2022 |
11 Aug 2022 17:18 | Financial Performance Quarter 2 (F45) (Reviewed) |
11 Aug 2022 17:18 | Management Discussion and Analysis Quarter 2 Ending 30 Jun 2022 |
11 Aug 2022 17:17 | Financial Statement Quarter 2/2022 (Reviewed) |
01 Aug 2022 18:07 | Report of the utilization of capital increase from IPO |
more
|
Company Profile |
Address |
No. 120, Moo 11, Ample Tower, 9th-10th Floor, Bangna-Trad Road, Bangna Bangkok 10260 |
Telephone |
0-2769-4222 |
Fax |
0-2769-4244 |
URL |
http://www.megawecare.com |
|
Annual Report 2021 |
Establish Date |
1982 |
Listed Date |
19/11/2013 |
IPO Price (Baht) |
17.50 |
@Par0.50 Baht |
IPO Financial Advisory |
KASIKORN SECURITIES PUBLIC COMPANY LIMITED
|
Par |
0.50 Baht |
Last Par Change |
N/A |
Business |
MEGA are a leading international manufacturer and distributor of pharmaceutical, nutraceutical products and Fast Moving Consumer Goods or FMCG . Currently, MEGA are a leading distributor in developing countries with high growth trends such as Myanmar, Vietnam and Cambodia. In addition, MEGA develop, manufacture, market and sell our own market leading brands of nutraceutical products, generic prescription pharmaceutical products, and OTC products under our Mega We CareTM brand through our distribution network and third party distributors in 35 countries across the world. |
Free Float |
09 Mar 2022 |
09 Mar 2021 |
% /Shareholders |
39.54% |
11,010 |
38.93% |
7,078 |
|
Foreign Shareholders |
12.51% (As of 16/08/2022) |
Foreign Limit |
100.00% |
NVDR Shareholders |
9.40% (As of 16/08/2022) |
|
|
5 Yr Price Performance (Adjusted Price) |
|
Price Performance (Adjusted Price) |
Compare to Stock (%) |
Compare to Sector (%) |
Compare to Market (%) |
5 Days |
-2.54 |
-2.66 |
-3.80 |
20 Days |
-9.00 |
-12.03 |
-14.40 |
60 Days |
-1.03 |
2.24 |
-3.80 |
120 Days |
10.98 |
21.06 |
15.85 |
YTD |
-4.95 |
-0.49 |
-3.34 |
P/E (X) |
18.26 |
31.56 |
17.95 |
P/BV (X) |
4.87 |
2.44 |
1.63 |
Turnover Ratio (%) |
0.27 |
0.40 |
0.92 |
|
Top 10 Major Shareholders(@09 Mar 2022) |
Share |
% |
1. |
บริษัท ยูนิสเตรทช์ จำกัด |
430,151,582 |
49.34 |
2. |
บริษัท Thai NVDR Company Limited |
82,767,546 |
9.49 |
3. |
นาย วิเวก ดาวัน |
45,982,716 |
5.27 |
4. |
SOUTH EAST ASIA UK (TYPE C) NOMINEES LIMITED |
14,616,800 |
1.68 |
5. |
STATE STREET EUROPE LIMITED |
13,619,201 |
1.56 |
6. |
BNP PARIBAS SECURITIES SERVICES, LONDON BRANCH |
13,430,000 |
1.54 |
7. |
THE BANK OF NEW YORK MELLON |
13,268,100 |
1.52 |
8. |
MR. PARAMJIT SINGH SAWHNEY |
13,085,395 |
1.50 |
9. |
น.ส. ดวงนภา ตงศิริ |
12,883,095 |
1.48 |
10. |
MINDO ASIA INVESTMENTS LIMITED |
7,270,400 |
0.83 |
Management |
Position |
1. |
Mr. MECHAI VIRAVAIDYA |
CHAIRMAN OF BOARD OF DIRECTOR / INDEPENDENT DIRECTOR |
2. |
Mr. ALAN CHI YIM KAM |
VICE CHAIRMAN OF THE BOARD OF DIRECTORS / INDEPENDENT DIRECTOR / CHAIRMAN OF AUDIT COMMITTEE |
3. |
Mr. VIVEK DHAWAN |
CHIEF EXECUTIVE OFFICER / DIRECTOR |
4. |
Mr. KIRIT SHAH |
DIRECTOR |
5. |
Mr. ISHAAN SHAH |
DIRECTOR |
6. |
Miss SAMEERA SHAH |
DIRECTOR |
7. |
Mr. SHIRAZ ERACH POONEVALA |
DIRECTOR |
8. |
Mr. THOMAS ABRAHAM |
DIRECTOR |
9. |
Mr. VIJAY PAUL KARWAL |
INDEPENDENT DIRECTOR / AUDIT COMMITTEE |
10. |
Mr. THOR SANTISIRI |
INDEPENDENT DIRECTOR / AUDIT COMMITTEE |
|
Statistics |
YTD 16 Aug 2022 |
2021 30 Dec 2021 |
2020 30 Dec 2020 |
Listed share (M.) |
871.87 |
871.87 |
871.87 |
Market Cap (MB.) |
41,849.74 |
44,029.41 |
31,169.33 |
Price (B./share) |
48.00 |
50.50 |
35.75 |
BVPS (B./Share) |
9.86 |
8.57 |
7.61 |
P/BV (X) |
4.87 |
5.89 |
4.70 |
P/E (X) |
18.26 |
23.45 |
23.13 |
Turnover Ratio (%) |
67.79 |
153.89 |
61.19 |
Value Trade/Day (MB.) |
190.86 |
240.15 |
71.74 |
Beta |
0.82 |
0.56 |
0.86 |
|
Rate of Return |
YTD |
2021 |
2020 |
Price Change (%) |
-4.95 |
41.26 |
37.50 |
Dividend Yield (%) |
2.88 |
1.78 |
2.01 |
Payout Ratio |
0.52 |
0.49 |
0.50 |
Dividend Policy |
Not less than 25 percent of the net profit of the Company after deduction of corporate income tax and legal reserve |
Dividend |
Operation Period |
Dividend/Share |
Unit |
Payment Date |
Type |
01 Jan 2021 - 31 Dec 2021 |
0.86 |
Baht |
22 Apr 2022 |
Cash |
01 Jan 2021 - 30 Jun 2021 |
0.52 |
Baht |
14 Sep 2021 |
Cash |
01 Jan 2020 - 31 Dec 2020 |
0.54 |
Baht |
23 Apr 2021 |
Cash |
01 Jan 2020 - 30 Jun 2020 |
0.36 |
Baht |
11 Sep 2020 |
Cash |
01 Jan 2019 - 31 Dec 2019 |
0.14 |
Baht |
28 Apr 2020 |
Cash |
- |
0.27 |
Baht |
28 Apr 2020 |
Cash |
01 Jan 2019 - 30 Jun 2019 |
0.31 |
Baht |
13 Sep 2019 |
Cash |
|
|
Auditor (Effective Until 31/12/2022) |
MISS SUREERAT THONGARUNSANG/KPMG PHOOMCHAI AUDIT LIMITED |
MISS VILAIVAN PHOLPRASERT/KPMG PHOOMCHAI AUDIT LIMITED |
Miss AORAPIN SINTHAWORNKUL/KPMG PHOOMCHAI AUDIT LIMITED |
|
F/S Year ended |
31/12 |
Latest Type of Report |
Unqualified opinion |
|
|
Statement of Financial Position (MB.) |
3M/2022 (01/01/22 -31/03/22) |
3M/2021 (01/01/21 -31/03/21) |
2021 (01/01/21 -31/12/21) |
2020 (01/01/20 -31/12/20) |
2019 (01/01/19 -31/12/19) |
Accounting Type |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Cash And Cash Equivalents |
2,240.72 |
1,490.46 |
2,197.69 |
1,006.45 |
1,247.92 |
A/R Net |
3,186.34 |
2,187.76 |
2,808.08 |
2,683.91 |
2,716.91 |
Inventories |
3,727.60 |
3,044.63 |
3,822.89 |
3,474.67 |
2,855.80 |
Current Assets |
9,620.39 |
7,380.40 |
9,300.88 |
7,619.82 |
7,245.84 |
PP&E Net |
1,915.71 |
1,923.06 |
1,837.31 |
1,950.98 |
1,770.59 |
Non-Current Assets |
4,019.40 |
4,050.57 |
3,970.82 |
3,969.89 |
3,286.87 |
Total Assets |
13,639.79 |
11,430.97 |
13,271.70 |
11,589.71 |
10,532.70 |
OD |
113.55 |
259.25 |
168.18 |
499.49 |
888.31 |
A/P Net |
3,325.21 |
2,394.75 |
3,532.72 |
2,788.49 |
2,508.04 |
Current portion of LT |
- |
- |
- |
- |
- |
Current Liabilities |
4,624.52 |
3,706.12 |
4,853.35 |
4,261.66 |
4,158.17 |
Non-Current Liabilities |
395.46 |
403.62 |
393.22 |
349.13 |
199.44 |
Total Liabilities |
5,019.99 |
4,109.74 |
5,246.58 |
4,610.79 |
4,357.61 |
Authorized Capital |
436.95 |
436.95 |
436.95 |
436.95 |
436.95 |
Paid-Up Capital |
435.94 |
435.94 |
435.94 |
435.94 |
435.94 |
Premium (Discount) on Share Capital |
2,304.52 |
2,304.52 |
2,304.52 |
2,304.52 |
2,304.52 |
Retained Earnings (Deficit) |
6,379.83 |
5,085.13 |
5,766.34 |
4,751.59 |
4,041.21 |
Treasury Stock |
- |
- |
- |
- |
- |
Shares Of The Company Held By Subsidiaries |
- |
- |
- |
- |
- |
Other Components Of Equity |
-522.73 |
-527.81 |
-505.98 |
-536.41 |
-608.68 |
- Surplus (Deficits) |
- |
- |
- |
- |
- |
Shareholders' Equity |
8,599.56 |
7,299.78 |
8,002.82 |
6,957.64 |
6,175.00 |
Minority Interest |
20.25 |
21.45 |
22.30 |
21.29 |
0.10 |
more |
|
Statement of Comprehensive Income (MB.) |
3M/2022 (01/01/22 -31/03/22) |
3M/2021 (01/01/21 -31/03/21) |
2021 (01/01/21 -31/12/21) |
2020 (01/01/20 -31/12/20) |
2019 (01/01/19 -31/12/19) |
Accounting Type |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Revenue From Operations |
3,823.08 |
3,272.59 |
14,145.69 |
12,589.41 |
11,129.78 |
Other Income |
10.40 |
7.95 |
36.67 |
23.61 |
33.93 |
Total Revenues |
3,833.48 |
3,280.53 |
14,182.36 |
12,613.02 |
11,163.72 |
Costs |
2,109.36 |
2,014.31 |
8,224.86 |
7,603.13 |
6,551.30 |
Selling And Administrative Expenses |
988.77 |
834.33 |
3,769.35 |
3,299.37 |
3,176.45 |
Total Cost And Expenses |
3,098.14 |
2,848.63 |
11,994.21 |
10,902.50 |
9,727.75 |
EBITDA |
789.34 |
479.74 |
2,579.59 |
1,951.38 |
1,525.77 |
Depre. & Amor. |
66.81 |
68.43 |
274.44 |
256.33 |
162.06 |
EBIT |
722.52 |
411.30 |
2,305.16 |
1,695.05 |
1,363.71 |
Net Profit : Owners Of The Parent |
613.99 |
333.55 |
1,946.83 |
1,392.65 |
1,138.52 |
EPS (B.) |
0.70 |
0.38 |
2.23 |
1.60 |
1.31 |
more |
|
Statement of Cash Flow (MB.) |
3M/2022 (01/01/22 -31/03/22) |
3M/2021 (01/01/21 -31/03/21) |
2021 (01/01/21 -31/12/21) |
2020 (01/01/20 -31/12/20) |
2019 (01/01/19 -31/12/19) |
Accounting Type |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Consolidate |
Operating Cash Flow |
230.74 |
932.38 |
2,726.82 |
1,629.43 |
1,495.11 |
Investing Cash Flow |
-119.84 |
-205.06 |
-264.68 |
-650.28 |
-172.47 |
Financing Cash Flow |
-75.00 |
-256.81 |
-1,313.88 |
-1,222.39 |
-621.31 |
Net Cash Flow |
35.89 |
470.51 |
1,148.26 |
-243.24 |
701.33 |
more |
|
Ratios |
3M/2022 |
3M/2021 |
2021 |
2020 |
Current Ratio (X) |
2.08 |
1.99 |
1.92 |
1.79 |
ROE (%) |
28.02 |
20.78 |
26.03 |
21.21 |
ROA (%) |
20.87 |
15.04 |
18.54 |
15.32 |
D/E (X) |
0.58 |
0.56 |
0.65 |
0.66 |
Total Asset Turnover (X) |
1.18 |
1.13 |
1.14 |
1.14 |
Gross Profit Margin (%) |
44.83 |
38.45 |
41.86 |
39.61 |
EBIT Margin (%) |
18.85 |
12.54 |
16.25 |
13.44 |
Net Profit Margin (%) |
15.98 |
10.14 |
13.69 |
11.01 |
Capital Movement (Last 3 Year) |
Date |
CA Type |
Changed paid up share |
Paid up share |
Par |
No Information Found |
|
Growth Rate (%) |
3M/2022 |
3M/2021 |
2021 |
2020 |
Sales Growth |
16.82 |
6.35 |
12.36 |
13.11 |
COGs Growth |
4.72 |
5.83 |
8.18 |
16.06 |
Total Revenue Growth |
16.86 |
6.44 |
12.44 |
12.98 |
Total Expense Growth |
8.76 |
5.78 |
10.01 |
12.08 |
Net Profit Growth |
84.08 |
4.24 |
39.79 |
22.32 |
Cash Cycle |
3M/2022 |
3M/2021 |
2021 |
2020 |
A/R Turnover (Times) |
6.04 |
5.22 |
5.40 |
4.66 |
Avg. Collection Period (Days) |
60.45 |
69.89 |
67.62 |
78.29 |
Inventory Turnover (Times) |
2.46 |
2.64 |
2.25 |
2.40 |
Avg. Inventory Period (Days) |
148.55 |
138.11 |
161.92 |
151.95 |
A/P Turnover (Times) |
4.09 |
3.27 |
3.09 |
2.87 |
Avg. Payment Period (Days) |
89.16 |
111.59 |
117.94 |
127.13 |
Cash Cycle (Days) |
119.84 |
96.41 |
111.61 |
103.11 |
|
Trading Sign (Latest) |
Trading Alert |
Posted Date |
Lifted Date |
No Information Found |
Market Alert (Latest) |
No Information Found |
more
|
|
Other Securities |
Securities Name |
- |
|
|
 |
Source: www.set.or.th (Copyright © The Stock Exchange of Thailand) |
|